ONCOLife Articles
Camizestrant Plus CDK4/6 Inhibition Boosts PFS in ESR1+, HR+/HER2– Breast Cancer
ONCOLife | 26 February 2025
No More Doubts: CDK 4/6 inhibitor + ET as First-Line Standard for HR+ mBC
ONCOLife | 24 February 2025
How Bayer Shapes Strategic Partnerships for the Next Generation of Cancer Therapies
ONCOLife | 20 February 2025
DNA-Based Immunotherapy IMNN-001 Promises to Improve Survival in Ovarian Cancer
Clinical Trials | 19 February 2025
New Data Confirms Darolutamide’s Safety and Efficacy in mHS Prostate Cancer
ONCOLife | 14 February 2025
How AI Innovations Are Transforming Breast Cancer Screening
ONCOLife | 30 January 2025
FDA Approves Innovative ADC Datroway for Metastatic HR+, HER2- Breast Cancer
FDA & EMA | 17 January 2025
Dr. Rafael Rosell Discusses the Efficacy of KRAS G12C Inhibitor in Lung Cancer Treatment
ONCOLife | 5 August 2024
Regulatory Approval Advances Pelareorep’s Virus Therapy for Pancreatic Cancer
ONCOLife | 15 January 2025
How AI Could Overcome Data Scarcity to Transform Medicine
AI | 10 January 2025
How Qvin's Q-Pad Could Transform Women’s Health Through Menstrual Blood Testing
ONCOLife
16 December 2024
Palbociclib Combination Yields PFS Improvement in HR+, HER2+ Breast Cancer
Clinical Trials
14 December 2024
Olaparib Shows Long-term Survival Benefits in BRCA+ and HER2- Breast Cancer
Clinical Trials
13 December 2024
IL-15 Agonist NKTR-255 Enhances CAR-T Therapy Effectiveness in LB-Cell Lymphoma
Clinical Trials
11 December 2024
Imlunestrant Shows Promising Results Alone and with Verzenio in ER+, HER2- Breast Cancer
Clinical Trials
12 December 2024
Blenrep Combination Reduces Death Risk by 42% in Relapsed Multiple Myeloma
Clinical Trials
10 December 2024
Breakthrough in First-Line Ovarian Cancer Treatment: KEYTRUDA and LYNPARZA
Clinical Trials
10 December 2024
FDA Grants Accelerated Approval to Bizengri for NRG1+ Pancreatic Cancer and NSCLC
FDA & EMA
5 December 2024
Fixed-Duration Acalabrutinib Plus Venetoclax Achieves Superior 77% PFS in Untreated CLL
Clinical Trials
9 December 2024
Adding Blinatumomab to Chemotherapy Extends 96% DF Survival in Pediatric Leukemia
Clinical Trials
8 December 2024
AI-Driven Cancer Therapy: Recursion Doses First Patient in REC-1245 Trial for Solid Tumors
AI
6 December 2024
AI-Powered PET/CT Analysis May Predict Side Effects of Immunotherapy in Lung Cancer
AI
29 November 2024
The FDA Approves IMKELDI, the First Oral Liquid Form of Imatinib, for Leukemia
FDA & EMA
27 November 2024
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
